サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1402540

欧州の点眼薬市場、2030年までの予測：地域別分析 - タイプ、用途、購入方法別

Europe Eye Drops Market Forecast to 2030 - Regional Analysis - by Type (Antibiotics, Artificial Tears, Hormones, and Others), Application, and Purchase Mode (OTC and Prescription)
出版日: | 発行: The Insight Partners | ページ情報: 英文 99 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
欧州の点眼薬市場、2030年までの予測：地域別分析 - タイプ、用途、購入方法別
出版日: 2023年11月07日
発行: The Insight Partners
ページ情報: 英文 99 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の点眼薬市場は、2022年の34億9,663万米ドルから2030年には50億9,311万米ドルに成長すると予測されています。2022年から2030年までのCAGRは4.8%と推定されます。

加齢に伴う眼疾患の高い発生率が欧州の点眼薬市場を後押し

目の視力低下は加齢によって顕著に引き起こされます。世界保健機関（WHO）のワールド・ビジョン・レポート（World Vision Report）によると、世界人口の高齢化に伴い、視力障害は公衆衛生上の重大な懸念事項として最前線に浮上しています。2020年には、110億人が未矯正の老眼または遠方視力障害を抱えています。これは2050年までに180億人に増加すると予測されています。白内障、加齢黄斑変性、緑内障、糖尿病性網膜症、老眼は、後期高齢者（60歳以上）に多く発症する一般的な視力障害の原因です。過去30年間で、視力障害と失明の年齢標準化有病率は減少したが、急速な高齢化によってこの減少は相殺され、その結果、失明と視力障害を持つ人が世界的に急増し、主に60歳以上の成人が増加しています。このように、高齢者の眼病有病率の高さは、メーカーに新しいアイケア製品の市場投入を促し、ひいては市場の成長に貢献すると思われます。また、ヘルスケア産業の発展により平均寿命が延びています。さまざまなヘルスケア企業が、高齢者人口に焦点を当てた製品を設計しています。世界各国は、高齢者を安全かつ効果的に治療するための新しい技術を導入しています。このように、高齢化人口の増加が市場成長の原動力となっています。

欧州の点眼薬市場概要

欧州の点眼薬市場は、ドイツ、英国、フランス、イタリア、スペイン、その他欧州に区分されます。同地域は欧州の点眼薬市場で大きなシェアを占めています。この地域の市場成長の背景には、欧州各国における様々な国内プレイヤーの存在感の高まりと、ドライアイ疾患の有病率の増加があります。ドイツでは多くの人々が眼疾患を抱えて生活しています。また、ドライアイの罹患率は同国の高齢者人口の間で増加しています。緑内障は、大衆の間でドライアイ状態を引き起こすもう一つの主要な要因です。ドイツでは、緑内障、白内障、網膜剥離などの眼科疾患が広く発生しています。ドイツにおける網膜剥離の発生率：2021年5月にOphthalmological Journal誌に発表された論文"Results from the Gutenberg Health Study"によると、ドイツにおける網膜剥離疾患の発症率は、35～74歳の年齢層で年間10万人当たり42人でした。他の欧州諸国の推計と比較すると、ドイツはこの年齢層での網膜剥離の発症率が高いと予測されました。

連邦統計局（Destatis）によると、ドイツでは2021年末までに67歳以上の人口が1,620万人に達し、2060年には2,160万人に増加すると予測されています。さらに、病気や視力障害は高齢者に多いです。今後数年間、ドイツでは高齢化率の上昇に伴い、眼に関連する疾患の発生率が増加することが予想されるため、同国における欧州の点眼薬市場の成長に拍車がかかることになります。

欧州の点眼薬市場の収益と2030年までの予測（金額）

欧州の点眼薬市場のセグメンテーション

欧州の点眼薬市場は、タイプ、用途、購入形態、国に区分されます。

タイプ別では、欧州の点眼薬市場は抗生物質、人工涙液、ホルモン剤、その他に区分されます。2022年の欧州の点眼薬市場では、抗生物質セグメントが最大のシェアを占めています。

用途別では、欧州の点眼薬市場は眼病、アイケア、その他に区分されます。眼疾患セグメントは2022年に欧州の点眼薬市場で最大のシェアを占めました。眼疾患セグメントはさらにドライアイ、緑内障、白内障、その他に区分されます。

購入形態に基づき、欧州の点眼薬市場はOTCと処方箋に区分されます。処方箋セグメントが2022年の欧州の点眼薬市場でより大きなシェアを占めています。

国別では、欧州の点眼薬市場はドイツ、英国、フランス、イタリア、スペイン、その他欧州に区分されます。2022年の欧州の点眼薬市場はドイツが独占。

AbbVie Inc、Akorn Operating Company LLC、Alcon AG、Bausch &Lomb Inc、Pfizer Inc、Prestige Consumer Healthcare Inc、Rohto Pharmaceutical Co Ltd、Sager Pharma Kft.、Similasan Corpは、欧州の点眼薬市場で事業を展開している大手企業です。

目次

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州の点眼薬市場情勢

  • 概観
  • PEST分析
    • 欧州PEST分析
  • パイプライン分析

第5章 欧州の点眼薬市場：主要産業力学

  • 市場促進要因
    • 眼科疾患の有病率の上昇
    • 加齢に伴う眼疾患の高い発生率
  • 市場抑制要因
    • 製品回収
  • 市場機会
    • アイケアへの取り組みの高まり
  • 今後の動向
    • ライフスタイルの変化
  • 影響分析

第6章 点眼薬市場：欧州市場分析

  • 欧州の点眼薬市場収益、2022年～2030年

第7章 欧州の点眼薬市場-収益と2030年までの予測：タイプ別

  • 抗生物質
  • 人工涙液
  • ホルモン剤
  • その他

第8章 欧州の点眼薬市場-収益と2030年までの予測：用途別

  • 眼疾患
  • アイケア
  • その他

第9章 欧州の点眼薬市場-収益と2030年までの予測：購入形態別

  • 処方薬
  • 一般用医薬品

第10章 欧州の点眼薬市場-収益と2030年までの予測：国別分析

第11章 欧州の点眼薬市場：業界情勢

  • 点眼薬市場における成長戦略
  • 有機的展開
  • 無機的展開

第12章 企業プロファイル

  • Alcon AG
  • Pfizer Inc
  • Prestige Consumer Healthcare Inc.
  • Rohto Pharmaceutical Co Ltd
  • AbbVie Inc
  • Bausch & Lomb Inc
  • Biomedica Pvt Ltd
  • Sager Pharma Kft
  • Similasan Corp

第13章 付録

図表

List Of Tables

List of Tables

  • Table 1. Europe Eye Drops Market Segmentation
  • Table 2. Germany: Europe Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Germany: Europe Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. Germany: Europe Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. Germany: Europe Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. France: Europe Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. France: Europe Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. France: Europe Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. France: Europe Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. UK: Europe Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. UK: Europe Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. UK: Europe Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. UK: Europe Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Italy: Europe Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Italy: Europe Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Italy: Europe Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Italy: Europe Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Spain: Europe Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Spain: Europe Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Spain: Europe Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Spain: Europe Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Rest of Europe: Europe Eye Drops Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Rest of Europe: Europe Eye Drops Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Rest of Europe: Europe Eye Drops Market, For Eye Diseases by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Rest of Europe: Europe Eye Drops Market, by Purchase Mode - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Organic Developments in the Eye Drops Market
  • Table 27. Inorganic Developments in the Eye Drops Market
  • Table 28. Glossary of Terms, Europe Eye Drops Market

List Of Figures

List of Figures

  • Figure 1. Europe Eye Drops Market Segmentation, By Country
  • Figure 2. Europe - PEST Analysis
  • Figure 3. Pipeline Analysis
  • Figure 4. Europe Eye Drops Market: Key Industry Dynamics
  • Figure 5. Europe Eye Drops Market: Impact Analysis of Drivers and Restraints
  • Figure 6. Europe Eye Drops Market Revenue (US$ Mn), 2020 - 2030
  • Figure 7. Europe Eye Drops Market Revenue Share, by Type 2022 & 2030 (%)
  • Figure 8. Antibiotics: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Artificial Tears: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Hormones: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Others: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Europe Eye Drops Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 13. Eye Diseases: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Dry Eye: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Glaucoma: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Cataract: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Others: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Eye Care: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Others: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Europe Eye Drops Market Revenue Share, by Purchase Mode 2022 & 2030 (%)
  • Figure 21. Prescription: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. OTC: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Europe Eye Drops Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 24. Europe Eye Drops Market, by Country, 2022 & 2030 (%)
  • Figure 25. Germany: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. France: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. UK: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Italy: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Spain: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Rest of Europe: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Growth Strategies in the Eye Drops Market (%)
目次
Product Code: BMIRE00029073

The Europe eye drops market is expected to grow from US$ 3,496.63 million in 2022 to US$ 5,093.11 million by 2030. It is estimated to grow at a CAGR of 4.8% from 2022 to 2030.

High Incidence of Age-Related Eye Diseases Fuels Europe Eye Drops Market

Weakening of eye vision is prominently caused by aging. According to the World Health Organization's World Vision Report, with an aging global population, vision impairment has risen to the forefront as a significant public health concern. In 2020, 11 billion people had uncorrected presbyopia or distance vision impairment. This amount is predicted to rise to 18 billion by 2050. Cataracts, age-related macular degeneration, glaucoma, diabetic retinopathy, and presbyopia are common causes of vision impairment that occur more frequently in later life (>60 years). Although, over the last 30 years, the age-standardized prevalence of vision impairment and blindness has reduced, this decrease has been offset by a rapidly aging population, resulting in a surging number of individuals with blindness and vision impairment globally, primarily adults over the age of 60. Thus, the high prevalence of eye disease among the older population is likely to encourage manufacturers to introduce new eye care products in the market, which, in turn, will contribute to the growth of the market. Also, the development in the healthcare industry has increased life expectancy. Various healthcare companies design products focusing on the geriatric population. Countries worldwide are adopting new techniques to treat older people safely and effectively. Thus, the growing aging population is driving the growth of the market.

Europe Eye Drops Market Overview

The Europe eye drops market in Europe is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant share of the Europe eye drops market. The market growth in this region is attributed to the growing presence of various domestic players across European countries and the increasing prevalence of dry eye disease. Numerous people in Germany are living with eye disorders. Also, the incidence of dry eye condition is increasing among the elderly population in the country. Glaucoma is another leading factor causing dry eye condition among masses. Germany records a widespread occurrence of ophthalmic conditions such as glaucoma, cataracts, and retinal detachments. According to the article "Incidence of Retinal Detachment in Germany: Results from the Gutenberg Health Study," published in the Ophthalmological Journal in May 2021, the incidence rate of retinal detachment disease in Germany was 42 per 100,000 people per year for the age group of 35-74 years. Compared to estimates from other European nations, the study projected that Germany has a higher incidence of retinal detachment in this age group.

As per the Federal Statistical Office (Destatis), ~16.2 million people in Germany were age 67 and above by the end of 2021, and the number is projected to rise to 21.6 million by 2060. Furthermore, illnesses and eyesight problems are more common among elderly people. The incidence of eye-related disease is expected to increase with the rising aging population in Germany in the coming years, thus fueling the growth of the Europe eye drops market in the country.

Europe Eye Drops Market Revenue and Forecast to 2030 (US$ Million)

Europe Eye Drops Market Segmentation

The Europe eye drops market is segmented into type, application, purchase mode, and country.

Based on type, the Europe eye drops market is segmented into antibiotics, artificial tears, hormones, and others. The antibiotics segment held the largest share of the Europe eye drops market in 2022.

Based on application, the Europe eye drops market is segmented into eye diseases, eye care, and others. The eye diseases segment held the largest share of the Europe eye drops market in 2022. The eye diseases segment is further segmented into dry eye, glaucoma, cataract, and others.

Based on purchase mode, the Europe eye drops market is segmented into OTC and prescription. The prescription segment held a larger share of the Europe eye drops market in 2022.

Based on country, the Europe eye drops market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe eye drops market in 2022.

AbbVie Inc, Akorn Operating Company LLC, Alcon AG, Bausch & Lomb Inc, Pfizer Inc, Prestige Consumer Healthcare Inc., Rohto Pharmaceutical Co Ltd, Sager Pharma Kft., and Similasan Corp are some of the leading companies operating in the Europe eye drops market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe Eye Drops Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe Eye Drops Market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

Table of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Eye Drops Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Europe PEST Analysis
  • 4.3 Pipeline Analysis

5. Europe Eye Drops Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Prevalence of Ophthalmic Diseases
    • 5.1.2 High Incidence of Age-Related Eye Diseases
  • 5.2 Market Restraints
    • 5.2.1 Product Recalls
  • 5.3 Market Opportunities
    • 5.3.1 Rising Initiatives for Eye Care
  • 5.4 Future Trends
    • 5.4.1 Changing Lifestyle
  • 5.5 Impact Analysis

6. Eye Drops Market - Europe Market Analysis

  • 6.1 Europe Eye Drops Market Revenue (US$ Mn), 2022 - 2030

7. Europe Eye Drops Market - Revenue and Forecast to 2030 - by Type

  • 7.1 Overview
  • 7.2 Europe Eye Drops Market Revenue Share, by Type 2022 & 2030 (%)
  • 7.3 Antibiotics
    • 7.3.1 Overview
    • 7.3.2 Antibiotics: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Artificial Tears
    • 7.4.1 Overview
    • 7.4.2 Artificial Tears: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Hormones
    • 7.5.1 Overview
    • 7.5.2 Hormones: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Eye Drops Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 Europe Eye Drops Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Eye Diseases
    • 8.3.1 Overview
    • 8.3.2 Eye Diseases: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.1 Dry Eye
        • 8.3.2.1.1 Overview
      • 8.3.2.2 Dry Eye: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.3 Glaucoma
        • 8.3.2.3.1 Overview
        • 8.3.2.3.2 Glaucoma: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.4 Cataract
        • 8.3.2.4.1 Overview
        • 8.3.2.4.2 Cataract: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.5 Others
        • 8.3.2.5.1 Overview
        • 8.3.2.5.2 Others: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Eye Care
    • 8.4.1 Overview
    • 8.4.2 Eye Care: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Eye Drops Market - Revenue and Forecast to 2030 - by Purchase Mode

  • 9.1 Overview
  • 9.2 Europe Eye Drops Market Revenue Share, by Purchase Mode 2022 & 2030 (%)
  • 9.3 Prescription
    • 9.3.1 Overview
    • 9.3.2 Prescription: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 OTC
    • 9.4.1 Overview
    • 9.4.2 OTC: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Eye Drops Market - Revenue and Forecast to 2030 - Country Analysis

  • 10.1 Europe Eye Drops Market
    • 10.1.1 Overview
    • 10.1.2 Europe Eye Drops Market, by Country, 2022 & 2030 (%)
      • 10.1.2.1 Germany: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 Germany: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.1.3 Germany: Europe Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 10.1.2.1.4 Germany: Europe Eye Drops Market, by Application, 2020-2030 (US$ Million)
        • 10.1.2.1.4.1 Germany: Europe Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
        • 10.1.2.1.5 Germany: Europe Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
      • 10.1.2.2 France: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 France: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.2.3 France: Europe Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 10.1.2.2.4 France: Europe Eye Drops Market, by Application, 2020-2030 (US$ Million)
        • 10.1.2.2.4.1 France: Europe Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
        • 10.1.2.2.5 France: Europe Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
      • 10.1.2.3 UK: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 UK: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.3.3 UK: Europe Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 10.1.2.3.4 UK: Europe Eye Drops Market, by Application, 2020-2030 (US$ Million)
        • 10.1.2.3.4.1 UK: Europe Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
        • 10.1.2.3.5 UK: Europe Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
      • 10.1.2.4 Italy: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.4.1 Overview
        • 10.1.2.4.2 Italy: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.4.3 Italy: Europe Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 10.1.2.4.4 Italy: Europe Eye Drops Market, by Application, 2020-2030 (US$ Million)
        • 10.1.2.4.4.1 Italy: Europe Eye Drops Market, For Antibiotics by Application, 2020-2030 (US$ Million)
        • 10.1.2.4.5 Italy: Europe Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
      • 10.1.2.5 Spain: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.5.1 Overview
        • 10.1.2.5.2 Spain: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.5.3 Spain: Europe Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 10.1.2.5.4 Spain: Europe Eye Drops Market, by Application, 2020-2030 (US$ Million)
        • 10.1.2.5.4.1 Spain: Europe Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
        • 10.1.2.5.5 Spain: Europe Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
      • 10.1.2.6 Rest of Europe: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.6.1 Overview
        • 10.1.2.6.2 Rest of Europe: Europe Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.2.6.3 Rest of Europe: Europe Eye Drops Market, by Type, 2020-2030 (US$ Million)
        • 10.1.2.6.4 Rest of Europe: Europe Eye Drops Market, by Application, 2020-2030 (US$ Million)
        • 10.1.2.6.4.1 Rest of Europe: Europe Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
        • 10.1.2.6.5 Rest of Europe: Europe Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)

11. Europe Eye Drops Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Eye Drops Market (%)
  • 11.3 Organic Developments
    • 11.3.1 Overview
  • 11.4 Inorganic Developments
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Alcon AG
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Pfizer Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Prestige Consumer Healthcare Inc.
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Rohto Pharmaceutical Co Ltd
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 AbbVie Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Bausch & Lomb Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Biomedica Pvt Ltd
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Sager Pharma Kft
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Similasan Corp
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms